APA (7th ed.) Citation

DA, G., MG, O., & PI, E. (2011). Once-daily administration of trospium chloride extended release provides 24-hr coverage of nocturnal and diurnal symptoms of overactive bladder: An integrated analysis of two phase III trials. Neurourology and urodynamics, 30(4), 563. https://doi.org/10.1002/nau.21018

Chicago Style (17th ed.) Citation

DA, Ginsberg, Oefelein MG, and Ellsworth PI. "Once-daily Administration of Trospium Chloride Extended Release Provides 24-hr Coverage of Nocturnal and Diurnal Symptoms of Overactive Bladder: An Integrated Analysis of Two Phase III Trials." Neurourology and Urodynamics 30, no. 4 (2011): 563. https://doi.org/10.1002/nau.21018.

MLA (9th ed.) Citation

DA, Ginsberg, et al. "Once-daily Administration of Trospium Chloride Extended Release Provides 24-hr Coverage of Nocturnal and Diurnal Symptoms of Overactive Bladder: An Integrated Analysis of Two Phase III Trials." Neurourology and Urodynamics, vol. 30, no. 4, 2011, p. 563, https://doi.org/10.1002/nau.21018.